Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Feb 15, 2024; 16(2): 398-413
Published online Feb 15, 2024. doi: 10.4251/wjgo.v16.i2.398
Published online Feb 15, 2024. doi: 10.4251/wjgo.v16.i2.398
Figure 2 Prohibitin 1 inhibits the proliferation of hepatocellular carcinoma cells.
A: The Prohibitin 1 (PHB1) mRNA and protein levels in hepatocellular carcinoma cells were investigated using real-time PCR (upper panel) and Western blot (lower panel), respectively; B-E: HepG2 and SMMC-7721 cell viability was determined using MTT assays after transfection with pEGFP-PHB1 (B and C) or PHB1-specific shRNA (shRNA-PHB1; D and E) for 24, 48, or 72 h. The data are presented as the mean ± SD of three independent experiments with similar results. aP < 0.05, bP < 0.01, cP < 0.001 vs L-02 cells. dP < 0.05 and eP < 0.01 vs control and empty vector/shRNA-control, respectively. PHB1: Prohibitin 1.
- Citation: Shi JJ, Wang YK, Wang MQ, Deng J, Gao N, Li M, Li YP, Zhang X, Jia XL, Liu XT, Dang SS, Wang WJ. Prohibitin 1 inhibits cell proliferation and induces apoptosis via the p53-mediated mitochondrial pathway in vitro. World J Gastrointest Oncol 2024; 16(2): 398-413
- URL: https://www.wjgnet.com/1948-5204/full/v16/i2/398.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i2.398